Zhang Yuan, Hou Xun-Rui, Li Li-Hong, Yang Meng, Liang Fei-Hong
Clinical Medical College of Guizhou Medical University, Guiyang 550004, China.
The Affliated Hospital of Guizhou Medical University, Guiyang 550004.
Zhen Ci Yan Jiu. 2017 Apr 25;42(2):141-4.
To observe the effect of acupoint injection on eosinophils (EOS) counts and expression of eotaxin in nasal mucosa of allergic rhinitis (AR) rats, so as to reveal its mechanism underlying improving AR.
Twenty-four Sprague-Dawley (SD) rats were randomly divided into normal, model and acupoint injection groups (=8 in each group). The AR model was established by intraperitoneal injection of ovalbumin sensitization. Bilateral "Yingxiang"(LI 20) and "Yintang"(GV 29) were selected for acupoint injection of the mixture solution of lidocaine, dexamethasone, and transfer factor (0.1 mL/acupoint) on the 1, 5, 9, and 13 day after AR model established, a total of four times. EOS in the nasal mucosa was counted under light microscope after HE staining. Protein and mRNA expressions of eotaxin in the nasal mucosa were detected by immunohistochemical and RT-PCR methods, respectively.
Compared with the normal group, EOS counts, protein and mRNA expressions of eotaxin in the nasal mucosa were significantly higher in the model group (<0.05). Compared with the model group, EOS counts, protein and mRNA expressions of eotaxin in the nasal mucosa were significantly lower in the acupoint injection group (<0.05).
Acupoint injection can reduce the nasal mucosa inflammation by suppressing the protein and mRNA expressions of eotaxin, decreasing the infiltration and gathering of EOS in the nasal mucosa.
观察穴位注射对变应性鼻炎(AR)大鼠鼻黏膜嗜酸性粒细胞(EOS)计数及嗜酸性粒细胞趋化因子(eotaxin)表达的影响,以揭示其改善AR的作用机制。
将24只Sprague-Dawley(SD)大鼠随机分为正常组、模型组和穴位注射组,每组8只。采用腹腔注射卵清蛋白致敏法建立AR模型。于造模后第1、5、9、13天,选取双侧“迎香”(LI 20)和“印堂”(GV 29)穴位注射利多卡因、地塞米松及转移因子混合溶液(0.1 mL/穴),共注射4次。HE染色后在光镜下计数鼻黏膜EOS。分别采用免疫组化法和RT-PCR法检测鼻黏膜eotaxin的蛋白和mRNA表达。
与正常组比较,模型组鼻黏膜EOS计数、eotaxin蛋白及mRNA表达均显著升高(<0.05)。与模型组比较,穴位注射组鼻黏膜EOS计数、eotaxin蛋白及mRNA表达均显著降低(<0.05)。
穴位注射可通过抑制eotaxin蛋白及mRNA表达,减少鼻黏膜EOS浸润聚集,减轻鼻黏膜炎症。